Aspira Women's Health Inc.
AWHL
$0.32
$0.013.23%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.71% | -3.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.71% | -3.34% | |||
| Cost of Revenue | 13.42% | -14.32% | |||
| Gross Profit | -25.52% | 3.98% | |||
| SG&A Expenses | -9.00% | 2.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.74% | -9.58% | |||
| Operating Income | -71.57% | 18.68% | |||
| Income Before Tax | 120.07% | 31.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 120.07% | 31.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 120.07% | 31.13% | |||
| EBIT | -71.57% | 18.68% | |||
| EBITDA | -69.67% | 16.63% | |||
| EPS Basic | 119.70% | 41.44% | |||
| Normalized Basic EPS | 115.20% | 24.05% | |||
| EPS Diluted | 34.31% | 41.44% | |||
| Normalized Diluted EPS | 114.42% | 24.05% | |||
| Average Basic Shares Outstanding | 1.62% | 17.62% | |||
| Average Diluted Shares Outstanding | 6.95% | 17.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||